Beihua Kong

Years Active: 2018-2020
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li, Beihua Kong
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer. Journal of ovarian research 13 (1) (2020)
Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li, Beihua Kong
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer. Journal of ovarian research 12 (1) (2019)
Hualei Bu, Jingying Chen, Qingshui Li, Jianqing Hou, Yuan Wei, Xiaohang Yang, Yana Ma, Hongsheng He, Youzhong Zhang, Beihua Kong
BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group. The journal of obstetrics and gynaecology research 45 (11) (2019)
Chengjuan Jin, Zhaojian Liu, Yingwei Li, Hualei Bu, Yu Wang, Ying Xu, Chunping Qiu, Shi Yan, Cunzhong Yuan, Rongrong Li, Nannan Diao, Zhiwei Zhang, Xiangxiang Wang, Lidong Liu, Beihua Kong
PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients. International journal of cancer 143 (11) (2018)

Beihua Kong.css-eqlu8i{font-size:small;padding-left:4px;}